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ABSTRACT
Objective: Redesign the conventional Mueller and Miller (MM) medium, without animal-derived (meat and blood) components, to produce tetanus 
toxin from Clostridium tetani.
Methods: Meat-based ingredients (such as bovine heart/brain/liver infusion) were replaced by vegetable peptone in combination with hydrolysate 
of casein in a modified MM medium and the production process scaled up from 100 to 1000 ml. Toxin concentration in terms of limes flocculation (Lf) 
was determined by Ramon flocculation test. Detoxification of tetanus toxin was carried out using formaldehyde to produce tetanus toxoid (TT). 
Purification of TT was achieved by fractional precipitation and ultra-filtration.
Results: It was found that under optimum conditions, the use of meat free media leads to production of tetanus toxin with equal Lf titer as obtained 
from conventional meat-based. The yield of toxin was improved during scale-up of the process.
Conclusion: This study provides a method for growth of Clostridium tetani that maximizes tetanus toxin production without any use of animal-
derived components.
Keywords: Clostridium tetani, Vegetable peptone, Hydrolysate of casein, Modified Mueller and Miller medium, Limes flocculation.
INTRODUCTION
Tetanus is a life-threatening disease and one of the world’s most prevalent 
diseases of humans and animals caused by bacillus Clostridium tetani [1]. 
The bacterium produces a neurotoxin called tetanospasmin, which blocks 
neurotransmission. Tetanus is a public health problem in many developing 
countries, particularly in tropical developing countries, where tetanus 
disease and deaths are dominated by maternal and neonatal tetanus.
Vaccination with tetanus toxoid (TT) has been practiced to prevent the 
disease. TT vaccines are used in expanded program of immunization 
in the most part of the world. It contains TT as antigen (Immunogen) 
adsorbed onto an adjuvant such as aluminum phosphate or aluminum 
hydroxide [2]. Commercially TT is manufactured as a single vaccine 
and as combination vaccines with diphtheria, whole-cell pertussis or 
acellular pertussis, inactivated polio, surface antigen of hepatitis B, and 
Haemophilus influenzae Type B polysaccharide.
C. tetani (Harvard strain), is a Gram-positive, anaerobic bacillus, being 
employed to produce tetanus toxin. This toxin is further converted to 
toxoid using either formaldehyde or glutaraldehyde by destroying the 
activity of the peptide toxin due to the generation of interpeptide cross-
links [3]. Tetanus toxin is converted to TT by formaldehyde by losing 
its immunogenic property. Tetanus toxin is generally produced by the 
growth of a highly toxicogenic strain of C. tetani in a suitable medium. 
The supernatant, which contains the tetanus toxin, is separated from 
the bacterium for detoxification and purification.
Mueller and Miller (MM) medium [4] which is conventionally used for 
tetanus toxin production contains complex ingredients such as bovine 
heart infusion (used as the primary nitrogen source) and pancreatic 
digest of casein. MM medium is sensitive to heat due to the presence of 
animal derived components. The imperfectly heated process could lead 
to the production of tetanus toxin contaminated with Maillard adducts 
and partially broken down products such as proteins and peptides of 
animal source.
The use of this meat-based medium for fermentation of C. tetani leads 
to the production of toxic hydrogen sulfide gas during the process. 
TT production by use of such medium can cause post-vaccination 
threats (transmissible spongiform encephalopathy and adventitious 
oncogenic viral transmission) in recipient, as there is possibility that 
toxoid preparations could contain undesirable protein contaminants 
such as prions and antigenic peptides [5]. Hence, there is need for 
the development of a modified medium for the production of TT that 
minimizes these health hazards and risks.
This study reveals that the media containing vegetable based 
components and new nitrogen source for growth of C. tetani can be 
similar to conventionally used growth medium containing meat derived 
products. In modified MM (MMM) medium, all other ingredients of 
medium are similar to those of conventional MM (such as vitamins, 
amino acids, inorganic salts, and energy source) except that all meat 
and blood-based products are substantially replaced with vegetable 
derived products. Some commonly used vegetable based products are 
Quest Hy-Soy® Quest NZ-Soy, DMV SE 50 MK, Quest NZ-Soy BL4®, Quest 
NZ-Soy BL7, DMV SE 50 M, Gibco Soy Peptone and Hi-veg, and Difco 
Bac-Soytone [6]. The comparison of the traditional conventionally used 
medium versus the MMM medium has been carried out repeatedly 
and observed consistently equal in terms of Lf titers and time of 
flocculation. The most significant outcome of this study is that use of 
modified meat free media reduces the post vaccination risks. Variation 
in toxin quality/yield at the time of batch to batch, due to the use of 




The present work was carried out in Research and Development 
Department of Chimera Gentec Pvt. Ltd., Greater Noida, India. Liquid 
working cell bank of C. tetani (Harvard Strain 49205) was revived in 
fluid thioglycollate medium (FTM) and incubated at 35±2°C for 24-48 
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hrs for pre-inoculum preparation. Growth of C. tetani in FTM was used 
for the preparation of seed culture. Seed medium was MMM medium 
which was same as fermentation medium. The medium contained 
glucose, disodium hydrogen phosphate, potassium dihydrogen 
phosphate, magnesium sulfate, uracil, tyrosine, cysteine, calcium-D 
pantothenate, riboflavin, biotin, vegetable peptone, and hydrolysate 
of casein. pH of the medium was adjusted to 7.5 with NaOH. The 
medium was distributed in 50 ml glass tubes and autoclaved at 121°C 
for 30 minutes. The inoculum medium-1 was inoculated with bacterial 
culture grown in FTM and incubated for 18-24 hrs at 35±2°C. Inoculum 
culture-1 was used for further sub-culturing (Inoculum culture-2) and 
preparation of final inoculums after sub-culturing.
Fermentation and scale up
The composition of the fermentation medium used for tetanus toxin 
production was kept same as seed medium that is MMM medium [3]. 
In the present work, we have studied the yield and quality of toxin 
during scale-up of the process as well as the efficiency of MMM medium 
as compared to conventional meat-based medium for tetanus toxin 
production. Initially, 25 ml of MMM medium in culture tube was used for 
fermentation process and then the process was scaled up by increasing 
the volume of fermentation medium to 100, 300, 1000, 1500, and 
2000 ml. The same composition of medium was used for fermentation 
and scale up as for the seed preparation. The media were sterilized 
by autoclaving at 121°C for 30 minutes. The fermentation medium 
was cooled down immediately after sterilization [7]. The production 
medium was inoculated with seed culture followed by incubation at 
35±2°C for 7-8 days. Process was scaled up from 25 ml starting volume 
up to 2000 ml. The sample was withdrawn on 5th, 6th and 7th day of 
incubation followed by centrifugation. The supernatant was used to 
analyze Lf content by flocculation method. Pellet containing cell mass 
was subjected to Gram’s-staining to check and confirm the disruption 
of cells. Total 20 batches were run to check the level of toxin production 
in different fermentation volumes.
Harvesting
The fermented broth was subjected to clarification by microfiltration to 
recover tetanus toxin in permeate. This method was carried out using 
tangential flow/cross flow filtration system (TFF) [8] in two different 
trials with cassette pore size of 0.22 µm and an effective filtration 
area of 0.1 m2. In TFF, particle or solutes retained by membrane were 
continuously removed in retentate flowing tangentially across the 
membrane surface. The cassette used was made up of microporous 
hydrophilic polyvinylidene difluoride. The system consisted of cassettes 
assembled in a holder with inlet, outlet, and permeate pressure gauges. 
Fermented broth was circulated at a flow rate of 1 L/min through 
the membrane using the peristaltic pump. Complete operation was 
carried out using permeate control valve system. Filtered toxin was 
collected aseptically through permeate line followed by determination 
of antigenic content by Lf method. After filtration of toxin, further 
processing involved toxoid preparation and purification of toxoid.
Toxin assay
Antigenic content of filtered toxin was estimated by adding a standard 
antitoxin, and measuring the elapsed time of flocculation [9,10]. It is 
an immunological precipitation test which is used for determination 
of antigenic content expressed as Lf/ml. Determination of toxin/
toxoid content was based on the fact that formation and subsequent 
precipitation of toxin/toxoid-antibody complexes is most prominent 
when the concentration of toxin/toxoid and antibody are equal in the 
reaction volume. Both Kf (the time in minutes required for flocculation) 
and limes flocculation (Lf; equivalent to one international unit of 
standard antitoxin, as established by flocculation) was recorded for 
the same. 1 ml aliquots of supernatant were taken in flocculation 
tubes. Tetanus antitoxin was added carefully in tubes with increased 
concentration. Tubes were incubated at 50±1°C in a water bath and 
were observed continuously. The tube with the fastest flocculation was 
selected.
Preparation of TT
TT was prepared by detoxifying the culture filtrate of C. tetani with 
0.4% formaldehyde. Formalin was diluted with an equal quantity of 
pre-sterilized water for injection before addition. pH of the solution 
was adjusted aseptically to 7.6±1°C with required volume of either 
1 N NaOH or 1 N HCl. The solution was left at room temperature for 
3-4 days. After 3-4 days of incubation at room temperature, pH of the 
solution was again checked and adjusted to 7.6±1 by either 1 N NaOH or 
1 N HCl. The solution was then incubated at 35±2°C for 42±2 days. After 
30±2 days of incubation, the sample was withdrawn for determination 
of Lf/ml content.
Purification of TT
After detoxification, the next important step in the process was the 
purification of TT, which was performed by concentration of TT followed 
by ammonium sulfate precipitation and diafiltration. The whole process 
was carried out in two different trials with the help of TFF technology. 
TT was concentrated 10 times (×10) before subjecting it to ammonium 
sulfate precipitation by using 30 kDa cassette with filtration area of 
0.1 m2. After fractional precipitation, ammonium sulfate and residual 
formaldehyde and other cellular by-products were removed by 
diafiltration of TT with purified water by using 10 kDa cassettes. On 
completion of diafiltration, purified TT was subjected to final sterile 
filtration through 0.2 μ filter followed by further determination of 
flocculation unit. Purified TT was stored at 2-8°C.
RESULTS AND DISCUSSION
The animal-based ingredients of MM medium were replaced with 
soy-based ingredients to develop a MMM medium and fermentation 
was carried out with different scale-up volumes to test the efficiency 
of vegetable peptone in combination of casein hydrolysate as an 
alternative component for tetanus toxin production [11]. Pellet from 
sample withdrawn on 5th, 6th, and 7th day of incubation followed by 
centrifugation, subjected to Gram’s staining shows more than 70% 
disruption of cells in all batches.
Results are summarized in Tables 1 and 2, which show consistent toxin 
yield with 11 batches. With volumes, more than 11, there was loss of Lf 
possibly due to the generation of hydrogen sulfide gas, which is toxic to 
bacterium. Out of 15 batches, most of the 11 batches showed good toxin 
yield consistently with 100 Lf/ml within 1-3 minutes that is almost 
equal to toxin yield using meat-based medium. Fermentation of 11 
Table 1: Toxin yield after 7 days incubation during scale up of 
fermentation volume





Kf (min) Kf (min) 
(Mean±SD)
1 25 40 41.7±2.8 3 3.6±0.5
2 25 45 4
3 25 40 3
4 30 45 41.7±2.8 3 4.6±1.5
5 30 40 5
6 30 40 6
7 300 100 96.7±8.3 4 3.6±0.5
8 300 95 3
9 300 95 3
10 1000 100 98.3±2.9 6 6±1
11 1000 100 6
12 1000 95 8
13 1500 90 88.3±2.9 5 6±1
14 1500 85 8
15 1500 90 7
16 2000 80 80±5 7 7±2
17 2000 75 8
18 2000 85 6
Sample volume: 10 ml/batch. SD: Standard deviation
Asian J Pharm Clin Res, Vol 9, Issue 6, 2016, 284-287
 Chawla et al. 
286
batches was carried out in 21 fermentation vessels. The fermentation 
volume was kept half the fermenter surface to maintain surface-to-
volume ratio in culture vessels, as when we conducted 1.5 and 21 
batches in same fermentation vessel, loss of Lf content in toxin was 
observed. Surface-to-volume ratio in culture vessels is an important 
factor for production of tetanus toxin [12].
It was found that Lf content of the fermented broth increases with the 
incubation period until 7th day of incubation. Table 2 shows the toxin 
yield in terms of Lf after 7th day incubation. The data show consistent 
results with 1000 ml fermentation volume in 2000 ml fermentation 
vessel. Since tetanus toxin is an exotoxin, it was released in fermentation 
medium, which was then separated from biomass by microfiltration. 
Supernatant obtained after microfiltration was used for further toxoid 
preparation.
Results in Tables 1 and 2 indicate that under optimum conditions, use of 
meat-free media leads to the production of tetanus toxin which is almost 
equal to Lf titer and time of flocculation as compared to conventional 
meat-based media.
Out of 15 batches, 13 batches showed consistent results. The present 
work also included scale-up of the process. A significant increase in 
Lf titers was observed during scale- up of the fermentation process. 
As a result, we now have a medium for production of tetanus toxin 
completely free from animal derived components at the beginning of 
the process all of the way to the end which is intended to give good Lf 
titer. In conventional MM medium, BHI is used as a source of nitrogen, 
which can be successfully replaced with vegetable and soy peptones 
without any loss of toxin yield and can be easily scaled up for 
commercial production. Lot to lot variation in toxin quality/yield due 
to use of NZ case can be reduced using alternate casein hydrolysate 
in the production process. Casein hydrolysate has a strong influence 
on both cell growth and production of tetanus toxin and also used for 
many other bacterial growth for high yield production [13]. There 
is probability of the presence of undesirable contaminants such as 
prions in final TT manufactured from meat-based medium, which 
may cause potential risk of post vaccination threats [14]. The use of 
modified meat free media significantly reduces post vaccination risks 
and makes it attractive for further studies on production in industrial 
scale.
Animal free media have been used in the past to manufacture some 
clostridia species. As early as 1971, it was shown that Clostridium 
perfringens could be grown successfully in a medium containing soy 
proteins [15]. In the last decade, there has been an emphasis in the 
human biological pharmaceutical industry to use soy-based media 
for manufacturing C. tetani and Clostridium botulinum. Because TT 
is a highly purified and concentrated antigen that is administered to 
humans, there is a much greater awareness and concern with potential 
contaminates like bovine spongiform encephalopathy (BSE). In 2007, a 
paper by Fang et al. outlined a soy based medium that was successfully 
used to manufacture TT [3]. Based on these studies, it is clear that 
clostridia strains can be readily grown in media free from animal 
products.
CONCLUSION
With the aim of removal of potential complex animal-derived 
components from the conventional medium, we developed a modified 
fermentation medium for tetanus toxin production which was 
intended to give equal Lf titers at par with conventional meat-based 
medium. This work has resulted in a effective way to produce the TT 
from C. tetani without the use of animal derived media components 
for the production of a toxoid vaccine. Carbon and nitrogen source 
in cultivation media plays a significant role as nutrition of bacterial 
growth [13,16-18]. The variable concentration can be optimized to 
improve the bacterial growth and productivity [19]. Replacing the 
animal components of growth media with vegetable-based components 
reduces the potential risk of contamination by biological molecules 
such as proteins and viruses that exist in animals. By way of example 
and without any limitation, these molecules include the protein agent 
that causes BSE, antigenic peptides that stimulate undesired immune 
reactions in immunized subjects and virally-contaminated animal 
products. By moving to a substantially animal-free manufacturing 
process, there will be an even greater emphasis on food safety and the 
prevention of new outbreaks of frighteningly devastating disease.
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